Isoenzymes of cyclic nucleotide phosphodiesterase in the human aorta: characterization and the effects of E4021

This publication has 20 references indexed in Scilit:

• Effects of a novel, selective and potent phosphodiesterase type V inhibitor, E4021, on myocardial ischemia in guinea pigs
  European Journal of Pharmacology, 1994
• Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterases and relaxation of rat aorta
  Biochemical Pharmacology, 1991
• Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
  Trends in Pharmacological Sciences, 1990
• Differential Vasorelaxant Effects of Milrinone and Amrinone on Contractile Responses of Canine Coronary, Cerebral, and Renal Arteries
  Journal of Cardiovascular Pharmacology, 1989
• Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta
  Biochemical Pharmacology, 1986
• Evidence that cyclic guanosine monophosphate (cGMP) mediates endothelium-dependent relaxation
  European Journal of Pharmacology, 1985
• Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle
  Biochemical Pharmacology, 1984
• Ca2+-induced hydrophobic site on calmodulin: Application for purification of calmodulin by phenyl-Sepharose affinity chromatography
  Biochemical and Biophysical Research Communications, 1982
• Subunit structure and catalytic properties of bovine brain calcium(2+) ion-dependent cyclic nucleotide phosphodiesterase
  Biochemistry, 1979
• Cyclic 3′:5′-nucleotide phosphodiesterase determined in various human tissues by deae-cellulose chromatography
  Biochimica et Biophysica Acta (BBA) - Enzymology, 1977